Skip to main content
. 2017 Jun 5;50(3):190–196. doi: 10.5090/kjtcs.2017.50.3.190

Table 2.

Postoperative outcomes

Variable All patients Propensity-matched patients


SP (n=37) MP (n=67) p-value SP (n=32) MP (n=32) p-value
Pleural adhesion 12 (32.4) 20 (29.9) 0.79 9 (28.1) 8 (25.0) 0.78

Incomplete fissure 26 (70.3) 47 (70.1) 0.99 22 (68.8) 22 (68.8) 1.00

Operation time (min) 210 (100–495) 200 (90–380) 0.41 210 (100–360) 200 (90–320) 0.11

Blood loss (mL) 170 (20–450) 180 (70–500) 0.44 170 (20–400) 160 (70–500) 0.19

Tumor diameter (cm) 2.3 (1.3–6.0) 2.5 (0.7–6.5) 0.49 2.5 (1.3–6.0) 2.5 (1.0–5.5) 0.53

No. of dissected lymph nodes 25 (10–63) 28 (10–75) 1.00 26 (10–53) 23 (14–48) 0.59

Explored nodal stations 6 (4–9) 6 (2–9) 0.09 6 (4–9) 7 (2–9) 0.24

Pathologic stages 0.60 0.79

 O 1 (1.5)

 IA 23 (62.2) 32 (47.8) 19 (59.4) 20 (62.5)

 IB 4 (10.8) 13 (19.4) 6 (18.8) 6 (18.8)

 IIA 5 (13.5) 12 (17.9) 3 (9.4) 3 (9.4)

 IIB 1 (2.7) 1 (1.5) 0 (0) 1 (3.1)

 IIIA 4 (10.8) 8 (11.9) 4 (12.5) 2 (6.3)

Chest tube (day) 5 (2–18) 6 (2–29) 0.56 5 (2–18) 6 (2–11) 0.66

Intensive care unit stay (day) 1 (1–2) 1 (1–26) 0.45 1 (1–2) 1 (1–2) 0.17

Hospital stay (day) 9 (6–22) 11 (5–29) 0.63 9 (6–22) 10 (5–28) 0.89

Wound size (cm) 4.5 (3.5–5.8) - 4.5 (3.5–5.5) -

Histologic type 0.92 1.00

 Adenocarcinoma 26 (70.3) 48 (71.6) 23 (71.9) 23 (71.9)

 Squamous cell carcinoma 8 (21.6) 15 (22.4) 7 (21.9) 7 (21.9)

 Other 3 (8.1) 4 (6.0) 2 (6.3) 2 (6.3)

Conversion 8 (17.8) 0 0.01 5 (15.6) 0 0.07

Values are presented as median (range) or number (%), unless otherwise stated.

SP, single-port; MP, multi-port.